Effects of dexmedetomidine on emergence delirium and electroencephalogram during the recovery period in older patients undergoing lower limb orthopedic surgery: A randomized, double-blind, placebo-controlled clinical trial

Jun Li,Chenxuan Ye,Panpan Fang,Jing Qian,Zixiang Shang,Xuesheng Liu
DOI: https://doi.org/10.1097/cm9.0000000000003191
IF: 6.133
2024-08-21
Chinese Medical Journal
Abstract:To the Editor: Delirium is a common postoperative complication associated with multiple adverse clinical outcomes in older patients. [ 1 ] According to the time of onset, delirium in the postoperative stage can be divided into emergence delirium (ED) and postoperative delirium (POD). ED occurs during or immediately after awakening from general anesthesia, whereas POD is usually found during postoperative days 1–7. Assessing patients for ED provides the first clue of a possible postoperative neurocognitive disorder. [ 2 ] Dexmedetomidine (DEX) is a highly selective α-2 receptor agonist that is increasingly used in the perioperative period to induce sedation, analgesia, anxiolysis, and sympathetic tone suppression. Previous studies suggested that DEX may be an effective intraoperative adjuvant drug, which can reduce agitation and improve recovery after orthopedic surgery in older patients. [ 3,4 ] However, few studies focused on the relationships between DEX and ED. This randomized controlled trial (RCT) aims to explore the relationships between intraoperative DEX administration and the incidence of ED in older patients undergoing lower limb orthopedic surgery, and examine the effects of DEX on the electroencephalogram (EEG) trajectories of older patients during the emergence period and its correlation with ED occurrence.
medicine, general & internal
What problem does this paper attempt to address?